Heart Failure Clinical Trial
Official title:
Decision Making for the Management for the Symptoms in Adults of Heart Failure: Randomized Clinical Trial
Introduction. Heart failure (HF) is the most prevailing chronic illness in the world. In
Colombia, high morbidity and mortality rates because of HF are registered, as well as a
significant burden of symptoms, frequent hospitalizations, poor quality of life, significant
consumption of health resources and early mortality. It is necessary to propose novel
strategies that can change the current picture.
Objective: determine the efficacy of an intervention centered in decision taking for the
handling of symptoms in adults with HF who live in the department of Cordoba, Colombia.
Hypothesis
Primary hypothesis: the intervention Decision taking for the handling of symptoms in adults
with HF: 1) Increases self-care.
Secondary hypothesis: 1) reduces clinical events: emergency care and hospitalizations, 3)
Improves quality of life related to health.
Intervention: The theoretic approach of the Theory of the Specific Situation Self-care in HF
was used for the design of the intervention.
Supplier/dosage/duration. The intervention was given by the researcher (nurse trained in the
intervention protocol) in three doses, each contact lasts 60 minutes. Frequency: sessions are
given once a week during a one-month period (duration). Nurse controls are implemented after
the intervention after one month and three months. There is also telephonic accompaniment on
application of the participant.
Delivery method/environment. Verbal: Individual face to face. Printed educational written
material type brochure, outpatient clinic of a health institution.
Methodology
Participants: inclusion criteria: adults (over the age of 18 years), more than two months of
having been diagnosed; functional New York Heart Association (NYHA) Class II - III, left
ventricular ejection fraction reduced (<40%). Cognitive state conservation (Lobo cognitive
mini exam - MEC-35). Absence or low co-morbidity (Charlson index). Exclusion criteria: acute
HF, advanced HF
Sample: The study was designed to have a 90% output, (alpha = 0.05), an expected difference
of 0.5 in the outcome score of the management and maintenance evaluation in both groups, a
standard deviation of outcome scores of 1.0, a correlation average between the first and the
second evaluation of 0.2 and a rate of wear of 20%. Therefore, the required final sample size
was 124 (62 per group - theoretic sample).
Pilot study: 176 adults with HF were recruited. 114 entered the study. 62 were excluded (did
not meet the inclusion criteria (n=39), did not want to participate (=14), other reasons
(n=9)).
Randomization. Table of random numbers without repetition. The Participants randomly assigned
to the control group CG (n=57) received the standard attention, including standard education
given by attention providers, and the ones assigned to the intervention group IG (n=57)
received the intervention protocol.
Information collection (research assistant). The study registers information in the following
time points: beginning (base line), follow up after a month (outpatient appointment), follow
up after 3 months (outpatient appointment). The study is classified as simple blind; the
research assistant, who is in charge of applying the instrument measuring the effect of the
intervention, will remain blinded during the whole study regarding the group assigned to each
participant.
Risk control. Compliance with methodological recommendations used to guarantee reliability
and validity of the research studies proving a clinic intervention for behavioral changes. A
plan is being contemplated that includes goals and strategies to monitor and counter possible
threats to internal and external validity.
Ethical aspects. Compliance with universal ethical principles for research on humans,
according to international ethical guidelines - CIOMS, national regulations, informed consent
and deontological Nursing responsibilities in Colombia.
Analysis framework Excel database - SPSS Program analysis
1. Descriptive analysis of the total sample and by groups (intervention and control):
absolute and relative frequency distributions; median and standard deviation.
2. Data normality analysis: Kolmogorov-Smirnov test Statistical analysis for independent
samples a) difference of proportions: X2, b) difference of means: t for student, c)
difference of medians: U test of Mann - Whitney. In all cases a statistic significance
will be assumed if the value p < 0.05.
3. Intrasubject and intergroup analysis: ANOVA with repeated measurements.
4. Hypothesis proof: W of Mauchly test. When the sphericity premise is fulfilled, test F
will be used.
5. Analysis of possible confusion and/or interaction effect.
1. Stratified analysis: X2 of Mantel-Haenszel (M-H),
2. Logistic regression analysis. Stepwise method. Minimum change % considered as
favorable (≥20=1, ≤19=0).
6. Analysis of the magnitude of the intervention's effect. Improvement of at least 20% of
the score on the scale, with the analysis principle of the intention of trying. The
absolute increase in benefit and the necessary number for treatment (NNT) will be
calculated afterwards.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT03087084 -
RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF)
|
N/A | |
Recruiting |
NCT03300791 -
Predictive Models of Readmission in Heart Failure
|
N/A | |
Completed |
NCT03294512 -
Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform
|
N/A | |
Recruiting |
NCT03565328 -
The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects
|
Phase 2 | |
Recruiting |
NCT03560167 -
Early Feasibility Study of the AccuCinch® Ventricular Repair System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
|
N/A | |
Active, not recruiting |
NCT03281122 -
A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction
|
Phase 1 | |
Recruiting |
NCT02275819 -
Exercise Training in Heart Failure: Changes in Cardiac Structure and Function
|
||
Completed |
NCT03238729 -
Proof-of-Concept Study of Heart Habits Application for Patients With Heart Failure
|
N/A | |
Not yet recruiting |
NCT02784912 -
Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation
|
N/A | |
Recruiting |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
Recruiting |
NCT02877914 -
China PEACE 5r-HF Study
|
N/A | |
Recruiting |
NCT03013270 -
Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure
|
N/A | |
Recruiting |
NCT02674438 -
Comparison of Outcomes and Access to Care for Heart Failure Trial
|
Phase 3 | |
Recruiting |
NCT02713126 -
Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF) (INABLE-Training)
|
Phase 2 | |
Recruiting |
NCT02823795 -
The Supporting Patient Activation in Transition to Home Intervention
|
N/A | |
Active, not recruiting |
NCT02911493 -
Reducing Sedentary Time in Patients With Heart Failure
|
N/A | |
Completed |
NCT02921607 -
Development of Scalable New Model(s) Focused on Care Co-ordination and Care Provision for Medically Complex, Co-morbid Chronic Disease Patient Segments Focusing on Heart Failure
|
||
Withdrawn |
NCT02624960 -
Safety and Performance of the AccuCinch® System
|
N/A |